Searched for
LOSARTAN POTASSIUM
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...- Pharma sector: Reasons to look at it beyond the tariff exemption. 7 pharma stocks with an upside potential of up to 43%Along with semiconductors, electronics and IT, pharma is another sector exempt from the Trump tariffs. Still, as the broader indices declin...
- Necessary pill for portfolio during volatility and Trump tariff wars: 8 pharma stocks with an upside potential of up to 48%Let’s accept the fact that we are likely to be dealing with volatility for the next four years. Both in the real world and in the global an...
- A Trump tariff tantrum-proof sector? 8 stocks from pharma sector, where Democrats and Republicans are in agreement, with an upside potential of up to 34% in 1 yearWhen Donald Trump is back in the saddle, one thing is certain: Tariff wars. Yes, China will be the biggest target. But for all those who th...
- As smog engulfs the street, essential pills for a healthy of portfolio: 5 pharma stocks with an upside potential of up to 39%Here’s a lesson from history: For a long-term investor, buying in a correcting market is mostly an opportunity. The operative part, of cour...
- Weekly Top Picks: 4 stocks with consistent score improvement & upside potential of up to 68%Is the up move of Nifty on friday, a dead cat bounce or it is the start of a sustainable rally. Rather than worrying about it is better to ...
- Granules gets USFDA nod to market generic medication to treat high blood pressureThe Hyderabad-based company's product is bioequivalent to the Organon LLC's Cozaar tablets.
- Stocks in the news: HDFC Bank, Coal India, Vedanta, MapmyIndia and Strides PharmaHDFC Bank, the largest private sector lender, said it has registered a 23 per cent growth in total advances in Maharashtra to Rs 3.28 lakh ...
- Strides Pharma recalls over 6 lakh bottles of blood pressure treatment tablets in USAs per the latest enforcement report by the US Food and Drug Administration (USFDA), the company, which is a unit of Bengaluru-headquartere...
- Torrent Pharma recalls 74k bottles of hypertension drug from USAs per the report, Torrent Pharma Inc is recalling 17,088 bottles of Losartan Potassium /Hydrochlorothiazide tablets, USP 50mg/12.5mg from ...
- After Market: IndusInd, Jet gain; DHFL, Cipla, TechM in the redThe market endured bouts of volatility throughout the day but there was decent buying in the last two hours of trade.
- Torrent Pharma falls 4% as co recalls Losartan Potassium tabletsThe report further added that the company is facing proposed class action in New Jersey Federal Court.
- Stocks in the news: ITC, HDFC, L&T, PCJ, SRF, Voda Idea and Torrent PharmaIDBI Capital has downgraded Eicher Motors to reduce from hold .
- Torrent Pharma recalls over 10.78 lakh bottles of hypertension drug from USThe US-based arm of Torrent Pharmaceuticals is recalling 133,992 bottles of Losartan Potassium tablets USP in the strength of 25 mg.
- Torrent Pharma recalls around 2.30 lakh bottles of high BP treatment tablets from USThe tablets were manufactured by Torrent Pharma in its Mehsana facility in India, the report said.
- Unichem gets USFDA nod for hypertension treatment tabletsThe product is generic version of Merck Sharp & Dohme Corp's Cozaar tablets in the strength of 25 mg, 50 mg and 100 mg, Unichem said.
- Apotex recalls about 92,000 bottles of hypertension drug in USThe drugs in various strengths including 25 mg, 50mg and 100 mg, were manufactured for Apotex Inc by Bengaluru based Apotex Research.
- Jubilant Life's four medicines get USFDA approvalJubilant Life Sciences said it has received approvals from the US health regulator for 4 products that target CNS and CVS therapeutic areas.
- Lupin recalls blood pressure drug in USLupin Ltd is recalling one batch of high blood pressure (BP) tablets losartan potassium from the US market after it exceeded the permissibl...
- Zydus Cadila gets US FDA nod to sale anti-blood pressure drugCadila got approval to market high blood pressure treatment tablets, Losartan Potassium and Losartan Potassium and HCTZ in the American mar...
Load More
